Cargando…
Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis
BACKGROUND: Mineral bone disease constitutes a common complication of post-kidney transplantation, leading to great disability. As there is no consensus on the optimal treatment for post-kidney transplant recipients (KTRs), we aimed to evaluate the efficacy and safety of bisphosphonate and its combi...
Autores principales: | Yang, Yan, Qiu, Shi, Deng, Linghui, Tang, Xi, Li, Xinrui, Wei, Qiang, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194739/ https://www.ncbi.nlm.nih.gov/pubmed/30340537 http://dx.doi.org/10.1186/s12882-018-1076-1 |
Ejemplares similares
-
Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials
por: Yang, Yan, et al.
Publicado: (2018) -
Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis
por: Kan, Shun-Li, et al.
Publicado: (2016) -
Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
por: Okamoto, Masanori, et al.
Publicado: (2014) -
Factors Related to Bone Metabolism in Kidney Transplant Recipients
por: Wang, Chenxiu, et al.
Publicado: (2021) -
The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients
por: Battaglia, Yuri, et al.
Publicado: (2023)